Alzheimer’s disease (AD) is the most prevalent of a large group of related proteinopathies forwhich there is currently no cure. Here, we used Drosophila to explore a strategy to block Aβ42 ...
Investigators at Yonsei University have reported findings from studies conducted to identify small molecules capable of disaggregating amyloid-β42 (Aβ42) aggregates, a hallmark of Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results